more

Cardinal Health (CAH)

(Real Time Quote from BATS)

$102.64 USD

-0.57 (-0.55%)

Updated Apr 29, 2024 03:42 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank	Definition	Annualized Return
1	Strong Buy	24.20%
2	Buy	18.04%
3	Hold	9.52%
4	Sell	5.20%
5	Strong Sell	2.60%
S&P	500	11.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5 3

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score	A
Growth Score	A
Momentum Score	A
VGM Score	A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth C Momentum A VGM

Industry Rank:

Top 38% (95 out of 252)

Industry: Medical - Dental Supplies

View All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Cardinal Health to Highlight Cost-Control Approach in ASHP

by Zacks Equity Research Published on November 28,2018

Cardinal Health (CAH) helps hospitals identify hidden savings, improve patient outcomes and drive supply chain efficiencies.

medical

Company News For Nov 8, 2018

by Zacks Equity Research Published on November 09,2018

Companies In The News Are: CAH,DHI,TRIP,WYNN

Cardinal Health (CAH) Surpasses Earnings Estimates in Q1

by Nabaparna Bhattacharya Published on November 08,2018

Cardinal Health (CAH) Q1 results benefit from strong sales in the Pharmaceutical and the Medical segments.

Cardinal Health (CAH) Beats on Earnings & Revenues in Q1

by Zacks Equity Research Published on November 08,2018

Cardinal Health's (CAH) solid segmental performance buoys optimism. FY19 view reiterated.

CAHNegative Net Change

Earnings Preview: Cardinal Health (CAH) Q1 Earnings Expected to Decline

by Zacks Equity Research Published on November 01,2018

Cardinal (CAH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CAHNegative Net Change

What's in Store for Cardinal Health's (CAH) Q1 Earnings?

by Zacks Equity Research Published on October 31,2018

Cardinal Health (CAH) likely to gain from solid Pharmaceutical revenues in fiscal Q1; medical-gloves sub-segment likely to be soft.

medical

New Strong Sell Stocks for October 17th

by Zacks Equity Research Published on October 17,2018

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

Why Is Cardinal (CAH) Up 0.9% Since Last Earnings Report?

by Zacks Equity Research Published on September 05,2018

Cardinal (CAH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

CAHNegative Net Change

Cardinal Health Product Spectrum Broad, Competition Rife

by Zacks Equity Research Published on August 17,2018

Cardinal Health's (CAH) strategic buyouts lend it a competitive edge; the Cordis unit lacks luster.

Cardinal Health (CAH) Surpasses Earnings Estimates in Q4

by Zacks Equity Research Published on August 06,2018

Cardinal Health (CAH) witnesses strong Q4, owing to strong sales at Pharmaceutical and the Medical segments. It provides an impressive FY19 view.

Cardinal Health (CAH) Q4 Earnings and Revenues Surpass Estimates

by Zacks Equity Research Published on August 06,2018

Cardinal (CAH) delivered earnings and revenue surprises of 8.60% and 2.32%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?

CAHNegative Net Change

Medical Product Stock Earnings on Aug 6: CAH, HSIC & More

by Zacks Equity Research Published on August 03,2018

The Medical product market gains momentum owing to the recent two-year suspension of the controversial 2.3% Medical Device tax.

3 Dental Stocks to Top Earnings Estimates This Season

by Zacks Equity Research Published on August 01,2018

On upbeat consumer sentiment and increased business investments, the dental supplies industry appears to be in the pink of health now.

Can Solid European Sales Boost Inogen (INGN) in Q2 Earnings?

by Zacks Equity Research Published on July 30,2018

Strong performance in Europe is likely to boost Inogen's (INGN) top line in Q2. However, decline rental-revenues is a concern.

Options Traders Expect Huge Moves in Cardinal Health (CAH) Stock

by Zacks Equity Research Published on July 26,2018

Cardinal Health (CAH) needs investors to pay close attention to the stock based on moves in the options market lately.

CAHNegative Net Change

What's in Store for Cardinal Health (CAH) in Q4 Earnings?

by Zacks Equity Research Published on July 24,2018

Cardinal Health (CAH) is likely to witness solid growth in the core Pharmaceutical segment in Q4 results. However, lackluster performance in the Cordis unit is likely to mar prospects.

Here's Why You Should Hold Onto Cardinal Health Stock Now

by Zacks Equity Research Published on July 23,2018

Cardinal Health's (CAH) unique portfolio of Medical and Pharmaceutical offerings will lend it a competitive edge in the MedTech space. However, the company faces sluggishness in the exam-gloves unit.